Medical Xpress August 12, 2024
Adam Pope, University of Alabama at Birmingham

New research published in The Lancet Regional Health-Americas from the University of Alabama at Birmingham School of Education and Human Sciences, College of Arts and Sciences, and Heersink School of Medicine found that the rollout of the COVID-19 vaccine in the United States was associated with decreased anxiety and depression rates among adults.

However, some groups—including Black Americans, non-Hispanic persons of color and lower-income adults—experienced worsened mental health after certain rollout phases.

Lead author of the paper, “Impact of phased COVID-19 vaccine rollout on anxiety and depression among US adult population, January 2019–February 2023: a population-based interrupted time series analysis,” and director of the UAB Community Counseling Clinic Yusen Zhai, Ph.D., says existing evidence already highlighted increased mental health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Healthcare System, Mental Health, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Technology, Trends
Related Articles:
The silent struggles of men’s mental health and suicide prevention
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
The Future of Behavioral Health Delivery
Fixing the Growing Payer-Provider Divide in Behavioral Health
Workers Feel “Stuck,” Under-Insured, Financially Stressed, and Neglecting Mental Health

Share This Article